Effect of adrenaline on myocardial oxygen consumption during selective and non-selective beta-adrenoceptor blockade comparison of atenolol and pindolol
- PMID: 6489425
Effect of adrenaline on myocardial oxygen consumption during selective and non-selective beta-adrenoceptor blockade comparison of atenolol and pindolol
Abstract
The effect of adrenaline on myocardial oxygen consumption (MVO2) during selective and non-selective beta-adrenoceptor blockade was examined in 26 patients with angina pectoris. Cardiac venous flow was measured by thermodilution and blood was sampled for metabolic studies. Thirteen patients were given atenolol 62.5 micrograms/kg i.v. and the other 13 patients pindolol 7.5 micrograms/kg i.v. Measurements were repeated before and during infusion of adrenaline 0.1 microgram/kg/min. Compared to the control situation, adrenaline increased MVO2 more in atenolol-treated (39%) than in pindolol-treated patients (11%). This was partly due to augmented external cardiac work. Arterial FFA was considerably increased in the atenolol group (105%), but was unchanged in the pindolol group, suggesting an additional metabolic mechanism. Thus, adrenaline stimulation, which is comparable to that found in acute myocardial infarction, increases MVO2 more during selective than non-selective beta-blockade.
Similar articles
-
Effects of atenolol and pindolol on the hypokalaemic and cardiovascular responses to adrenaline infusion.Eur J Clin Pharmacol. 1989;37(1):23-7. doi: 10.1007/BF00609418. Eur J Clin Pharmacol. 1989. PMID: 2591459 Clinical Trial.
-
Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.Angiology. 1990 Mar;41(3):175-88. doi: 10.1177/000331979004100302. Angiology. 1990. PMID: 1968731 Clinical Trial.
-
Effects of cardioselective and non-cardioselective beta-blockade on adrenaline-induced metabolic and cardiovascular responses in man.Eur J Clin Pharmacol. 1981;20(1):17-22. doi: 10.1007/BF00554661. Eur J Clin Pharmacol. 1981. PMID: 6118277
-
The effect of pindolol on myocardial blood flow, metabolism and function during rest and pacing in patients with coronary heart disease.Br J Clin Pharmacol. 1982;13(Suppl 2):309S-312S. doi: 10.1111/j.1365-2125.1982.tb01932.x. Br J Clin Pharmacol. 1982. PMID: 7104152 Free PMC article.
-
Haemodynamic effects of atenolol, pindolol and propranolol during adrenaline infusion in man.Eur J Clin Pharmacol. 1986;30(6):659-63. doi: 10.1007/BF00608212. Eur J Clin Pharmacol. 1986. PMID: 3533564 Clinical Trial.
Cited by
-
Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.Drugs. 1991 Sep;42(3):468-510. doi: 10.2165/00003495-199142030-00007. Drugs. 1991. PMID: 1720383 Review.
-
Effects of atenolol and pindolol on the hypokalaemic and cardiovascular responses to adrenaline infusion.Eur J Clin Pharmacol. 1989;37(1):23-7. doi: 10.1007/BF00609418. Eur J Clin Pharmacol. 1989. PMID: 2591459 Clinical Trial.